DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.

Cancer Research
Hong WangFen Xia

Abstract

The tumor suppressor BRCA1 is a nuclear shuttling protein. However, the role of BRCA1 localization in the control of its functions remains to be elucidated. Given the central role of BRCA1 in DNA damage repair, we hypothesized that depletion of nuclear BRCA1 would compromise its nuclear function in DNA repair and thereby result in enhanced cytotoxic response to DNA damage. In this study, we showed that repair of DNA double-strand breaks required BRCA1 in the nucleus. In addition, sequestering BRCA1 in the cytosol enhanced the cytotoxic response to ionizing radiation or cisplatin in human breast and colon cancer cells. However, further genetic dissection of the mechanism of this enhanced cytotoxicity using BRCA1 mutants deficient in double-strand break repair unexpectedly revealed a dissociation of BRCA1's function in DNA repair from its effects on cellular sensitivity to DNA damage. Interestingly, we observed a dependence of the DNA damage-induced cell killing on the translocation and accumulation of BRCA1 in the cytosol. Together, these data suggest a novel role of cytoplasmic translocation of BRCA1, not only in controlling its DNA repair functions, but also in the regulation of cell death processes following DNA damage. Furth...Continue Reading

References

Oct 7, 1994·Science·P A FutrealY Miki
Jan 15, 2000·Molecular Cell·R ScullyD M Livingston
Sep 19, 2000·The Journal of Biological Chemistry·J A Rodríguez, B R Henderson
Feb 8, 2002·Cell·Ashok R Venkitaraman
Jan 1, 2004·Molecular and Cellular Biology·Junran ZhangFen Xia
Jan 20, 2004·Experimental Cell Research·José Antonio RodriguezBeric R Henderson
Jan 28, 2004·Cell·Nika N Danial, Stanley J Korsmeyer
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sharon CantorDavid M Livingston
Apr 17, 2004·The Journal of Biological Chemistry·Zhihui FengFen Xia
Jul 22, 2004·Experimental Cell Research·Megan FabbroBeric R Henderson
Apr 7, 2005·The Journal of Biological Chemistry·Marilyn E ThompsonJeffrey T Holt
Sep 14, 2006·Cell Cycle·Jeffrey D Parvin, Satish Sankaran
Dec 12, 2007·Apoptosis : an International Journal on Programmed Cell Death·Eva DizinNicole Dalla Venezia

❮ Previous
Next ❯

Citations

May 29, 2012·Cancer Letters·Somaira NowsheenAlexandros G Georgakilas
Nov 14, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela J ZiebarthCharles N Landen
Jun 28, 2013·PloS One·Estelle DacheuxNicole Dalla Venezia
Nov 5, 2013·Antioxidants & Redox Signaling·Wil L Santivasi, Fen Xia
Jan 10, 2012·Biochemical Pharmacology·Michelle Martinez-Rivera, Zahid H Siddik
Jul 4, 2012·Human Mutation·Gaël A MillotUNKNOWN ENIGMA Consortium Functional Assay Working Group
Aug 6, 2011·Journal of Applied Toxicology : JAT·Haseeb Ahmad Khan, Abdullah Saleh Alhomida
Aug 25, 2015·Cancer Letters·Nadire DuruQun Zhou
Jun 10, 2015·British Journal of Cancer·W L SantivasiFen Xia
Jun 9, 2012·Mutation Research·Corentin Laulier, Bernard S Lopez
Jul 2, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Somaira NowsheenEddy S Yang
Jun 28, 2016·Oncology Letters·Yingqiu XieTursonjan Tokay
Mar 30, 2011·Cancer Research·Corentin LaulierBernard S Lopez
Mar 30, 2018·Molecular Cancer Research : MCR·Steven T SizemoreFen Xia
Jan 10, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Liliana RaimundoLucília Saraiva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.